News and Trends 23 Dec 2022
Mersana Therapeutics and Merck to develop novel ADCs
Mersana Therapeutics, Inc. has announced a research collaboration and commercial license agreement with a subsidiary of Merck KGaA, Darmstadt, Germany to discover novel Immunosynthen antibody drug conjugates (ADCs) directed against…